Merck, in partnership with NJII, announced the launch of the Merck Digital Sciences Studio to enable the generation of innovative technologies for drug discovery and development.

New Jersey Innovation Institute (NJII) announced the sale of its subsidiary, BioCentriq Inc., to GC corp. for $73 million. BioCentriq manufactures autologous and allogeneic cell therapies and gene therapies and specializes in viral vector production, cell and viral banking, and upstream and downstream processing.

This year ROI-NJ presents the first-ever ROI Influencers Technology list which includes New Jersey Tech Leaders in various categories. Dr. Joel Bloom, president, NJIT and Chairman of NJII Board of Directors and Nariman Farvardin, president, …

NJII welcomes three new members to its board of Directors from Newark Venture Partners, NJ Hospital Association and Girls with Impact.

This year’s ROI Influencers: Power List rankings from ROI NJ includes the 30 most influential people in the state, with Governor Phil Murphy topping the list and NJII Board Member, CEO of Choose New Jersey, …

Earlier this week, New Jersey Innovation Institute CEO Simon Nynens spoke with the New Jersey Health Care Quality Institute (NJHCQI), a nonprofit coalition devoted to improving healthcare in the Garden State. His “Take Five Interview” …

April 20, 2020, Newark, NJ – New Jersey Innovation Institute’s (NJII) announced today that Jennifer D’Angelo will join NJII as a Vice President and General Manager, effective May 4th. She will lead the Healthcare division. …

The New Jersey Innovation Institute (NJII) has appointed Dr. Deirdre Letson-Christofalo as vice president of its Human Capital Division and Dan Kaminski as vice president and general manager of Data & Technology. Both units were …

NEWARK, NJ, Dec 17, 2019 – New Jersey Innovation Institute (NJII) President, Donald H. Sebastian and NJII Board Members, Dean Paranicas, Michele Siekerka and Debbie Hart have been named to the NJBIZ Manufacturing Power 50 for …

New Jersey Innovation Institute (NJII) is marking the end of 2019 with a leadership addition. Simon Nynens has assumed the role of chief executive officer. Nynens is not new to NJIT. He has served as …

NEWARK, NJ, October 8, 2019 – Donald H. Sebastian, NJII CEO and president, Tomas Gregorio, senior vice president NJII healthcare division and Haro Hartounian, senior executive director NJII biotechnology and pharmaceutical innovation have been named to …

NJII President and CEO, Dr. Donald H. Sebastian has been named a 2019 Icon Award winner by NJBIZ.  The Icon Awards recognize New Jersey Business Leaders who have, and continue to, help grow and encourage …